At Tri-Con, Researchers Present Novel PCR Approaches to Liquid Biopsy | GenomeWeb

SAN FRANCISCO (GenomeWeb) – At Cambridge Healthtech Institute's Molecular Medicine Tri-Conference here this week, a pair of Boston-based researchers presented novel approaches for the detection of circulating nucleic acid biomarkers for potential use in cancer diagnosis and disease monitoring.

The scientists — Chen Song, a research fellow with Dana-Farber Cancer Institute and Harvard Medical School, and Leonora Balaj, a research fellow at Massachusetts General Hospital and Harvard Medical School — discussed their methods in the "PCR for Molecular Medicine" track on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Sponsored by

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.